Continuing Education credits for the East Coast Symposium are provided by the HMP Education.
Additional credit applications and approvals are pending. This page will be updated upon approval.
Please contact info@HMPeducation.com for any specific requests or more information.
East Coast Symposium Audience
This activity has been designed to meet the educational needs of physicians, pharmacists, advanced practice registered nurses, registered nurses, social workers, addiction professionals, prevention professionals, health education specialists, certified counselors, and psychologists.
Joint Accreditation Statement
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
This activity has been approved to offer AMA PRA Category 1 Credit(s)™.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria.
This continuing nursing education activity has been approved to offer continuing contact hours for nurse professionals.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
HMP Education is approved by the American Psychological Association to sponsor continuing education for psychologists. HMP Education maintains responsibility for this program and its content.
Instructional Level: Advanced
NAADAC Addiction Professionals
This course has been approved by HMP Education, as a NAADAC-Approved Education Provider, to provide educational credits. NAADAC Provider #182840. HMP Education is responsible for all aspects of the programming.
ASWB—Association of Social Work Boards
As a Jointly Accredited Provider, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. HMP Education maintains responsibility for this course.
This continuing pharmacy education activity has been approved to offer continuing contact hours for pharmacy professionals.
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in CPE Monitor system. The deadline to claim credit is 60 DAYS AFTER ACTIVITY. Following ACPE Policy, HMP Education will not be able to report your claimed credit to CPE Monitor after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended.
East Coast Symposium, 2022 has been approved by NBCC for NBCC credit. Sessions approved for NBCC credit are clearly identified. HMP Education, LLC is solely responsible for all aspects of the program. NBCC Approval No. SP-3995.
1. Mindfulness Oriented Recovery Enhancement An Innovative Neuroscience-Based Treatment to Help Heal the Opioid Crisis (Eric L. Garland, PhD)
2. Sexual Boundary Violations by Professionals (Philip Hemphill, PhD, LCSW)
3. Differential Diagnoses & Treatment of Mental Health and Substance Use Disorders (Amishi Mehta, MD and Deni Carise, PhD)
4. Clinical and Ethical Issues in Managing Suicide Risk in People Using Substances (John J. O'Neill, EdD, LCSW, LCDC)
5. Facilitated Growth - Experiential Activities for Recovery and Wellness (Marc V. Pimsler, MA, LPC, CET3)
6. Wholehearted Journey to Ethics (Maeve O'Neill, MEd, LCDC, LPC-S, CHC, CDWF/CDTLF)
7. What to Consider When Addiction Treatment isn't Working: Lessons Learned from Cognitive Science (Bruce Liese, PhD, ABPP)
8. Pain and Addiction: Feeling Safe Enough to Heal (Les Arias, PhD and Mel Pohl MD, DFASAM)
9. Understanding & Addressing Post Pandemic Trauma Impact (Kenneth L. Roberts, MPS, LPCC, LADC)
10. Sexual Violence in LGBTQIA+ Communities (Philip McCabe, CSW, CAS, DRCC)
11. How Constructed Narratives Impact Substance Use and Other Mental Health Diagnoses (Elizabeth Kunreuther, MSW, LCSW, LCAS)
12. Medication Assisted Treatment for Opioid Use Disorder (Harry L. Haus, MD, JD)
13. Alcohol Use Disorder and Treatment Options, Including Behavioral and Medication Interventions (Valerie A. Carrejo, MD, FAAFP, FASAM)
14. ADHD and Substance Use Disorders: Knowing is Preventing (Trish Caldwell, MFT, LPC, CAADC, CCDP-D, CCTP)
15. Kids In Context: Organizational Readiness to Treat Adolescents with Substance Use and Other Behavioral Challenges (Katie R. Berry, PhD)
16. Health, Wellness, and Quality of Life Satisfaction Among Persons Receiving Medication for Opioid Use Disorder (Rhonda G. Patrick, PhD, LCSW-S, MPA)
17. Adverse Childhood Experiences and the Justice-Involved Population: What to Know (David Dawdy, MA, LLP)
18. Somatic Experiencing (SE) and Dance-Movement Therapy (DMT): Clinical Implications of Incorporating Body-Oriented Modalities (Amy VanBecelaere, LCPC, R-DMT and Lesley A. Tate-Gould, PsyD, SEP)
19. Integrating Substance Use and Trauma Treatment: How Cognitive Processing Therapy can Provide Relief for Those Suffering from Trauma (Kelly Souza, PsyD)
20. Medication for Addiction Treatment (MAT): Current Trends & Controversies (Jake Nichols, PharmD, MBA)
21. We Say Addiction is a Family Disease! Is It? (Michael Barnes PhD, MAC, LPC and Mary R. Woods, MSHS/LADC, BC-RN, LCS)
22. Psychedelics and Substance Use Disorder: Past, Present, and Future (Joji Suzuki, MD)
23. Harm Reduction for Skeptics: Practicing Alcohol Moderation in a Post-Pandemic World (Craig James, LCSW, LSATP, MAC and Cyndi Turner, LCSW, LSATP, MAC)
24. Multidimensional Treatment of Young Adults with Complex Clinical Profiles in a Community Model Setting: Why It’s Necessary and How it Works (Brittany Becker, LMHC)
25. Protocol for use of Buprenorphine Long Acting Formulations (David Mathis, DO)
26. New Technologies for Measuring, Monitoring and Mitigating the Role of Stress in Addiction (Evian Gordon MD, PhD)
27. Medication Assisted Therapy (MAT) and Transitions of Care in Opioid Use Disorder (Janet L. Wilkinson, MSN)
28. Medications for Opioid Use Disorder Save Lives: Closing the Treatment Gap (Steven L. Proctor, PhD)
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 770.751.7332/609.371.1137.
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
2. any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, identified those with the potential to compromise the goals and educational integrity of the education and mitigated any conflict of interest. Relevant relationships, or lack thereof, are shared with the learner.
Supported education has been independently peer-reviewed to validate content and faculty with relevant relationships have attested that:
1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education, LLC, may contact Samantha Conforti, Senior Manager, Accreditation & Compliance, by phone at 609.630.6208, by email at firstname.lastname@example.org, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation & Outcomes, Andrea Zimmerman, can be requested for a second level of review. Ms. Zimmerman can be contacted via phone at 609.371.1137 x4111, by email at email@example.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
No commercial interest provided financial support for this continuing education activity.